EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

BTK‐Inhibition Enhances TLR‐7‐Mediated Interferon‐Alpha Production in pDCs by Blocking the Inhibitory BDCA‐2 Pathway

Laura Ceglarek iD, Ramona Gerhards, Vinicius Boldrini, Christian Wichmann, Anneli Peters, Edgar Meinl iD

European Journal of Immunology · 2025

DOI: 10.1002/eji.202450985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Laura Ceglarek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, Agammaglobulinaemia Tyrosine Kinase, Interferon-alpha, Dendritic Cells. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CAPES/Alexander von Humboldt (AvH)-Stiftung : Call 19/2022 (research fellowhip to VB), Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Toll-Like Receptor 7Agammaglobulinaemia Tyrosine KinaseInterferon-alphaDendritic CellsHumansSignal TransductionAnimalsToll-Like Receptor 9Lupus Erythematosus, Systemic

Stichwörter der Autor:innen

BTK‐iTLR signalingmultiple sclerosispDCssystemic lupus erythematosus

Substanzen

Toll-Like Receptor 7Agammaglobulinaemia Tyrosine KinaseInterferon-alphaBTK protein, humanTLR7 protein, humanToll-Like Receptor 9

Autor:innen und Institutionen

  • Institute of Clinical Neuroimmunology, Biomedical Center and University Hospital, Ludwig-Maximilians-Universität München, Munich, Germany.
  • Center for Human Immunology, University of Zurich, Zurich, Switzerland.
  • Department of Transfusion Medicine, Cell Therapeutics and Hemostaseology, University Hospital, LMU Munich, Munich, Germany.

ORCID-Profile: Laura Ceglarek, Edgar Meinl

Förderung

  • CAPES/Alexander von Humboldt (AvH)-Stiftung : Call 19/2022 (research fellowhip to VB)
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Ceglarek, L., Gerhards, R., Boldrini, V., Wichmann, C., Peters, A., & Meinl, E. (2025). BTK‐Inhibition Enhances TLR‐7‐Mediated Interferon‐Alpha Production in pDCs by Blocking the Inhibitory BDCA‐2 Pathway. European Journal of Immunology. https://doi.org/10.1002/eji.202450985

Vancouver

Ceglarek L, Gerhards R, Boldrini V, Wichmann C, Peters A, Meinl E. BTK‐Inhibition Enhances TLR‐7‐Mediated Interferon‐Alpha Production in pDCs by Blocking the Inhibitory BDCA‐2 Pathway. European Journal of Immunology. 2025. doi:10.1002/eji.202450985

BibTeX
@article{Ceglarek2025,
  author = {Ceglarek, Laura and Gerhards, Ramona and Boldrini, Vinicius and Wichmann, Christian and Peters, Anneli and Meinl, Edgar},
  title = {BTK‐Inhibition Enhances TLR‐7‐Mediated Interferon‐Alpha Production in pDCs by Blocking the Inhibitory BDCA‐2 Pathway},
  journal = {European Journal of Immunology},
  year = {2025},
  doi = {10.1002/eji.202450985}
}
Kostenlos starten →